Importer of Controlled Substances; Notice of Registration, 36693-36694 [2010-15557]
Download as PDF
<![CDATA[
Federal Register / Vol. 75, No. 123 / Monday, June 28, 2010 / Notices
36693
should be considered null and void.
Election Systems & Software (ES&S)
should not have the right to ever pursue
former Premier Associates in legal
matters with respect to those
Agreements. The Agreements should
not be void as of the Date of the Final
Judgment as some of these former
employees have already started working
with other vendors. These former
employees would be subject to legal
action from ES&S since they wouldn’t
fall within the window set forth in the
Final Judgment. These Agreements
should be considered void as of the date
of the employee’s termination date. Also
the agreements are already set to expire
in September 2011 so there is no reason
to have a 6 month window for any
acquirer to hire these former employees.
These former employees should also be
able to go to work for any company in
the election industry, not just the
acquirer, without fear or threat from
ES&S. Below is my consideration to the
wording set forth in the Final Judgment.
All restrictive covenants contained
within any employment agreement or
separation agreement entered into
between Premier Election Solutions,
Inc., its parent corporation, subsidiaries,
officers, directors, supervisors and/or
representatives (collectively referred to
as ‘‘Premier’’) and any individuals
formerly employed by Premier who
were terminated in 2009 are declared
void. Premier may not institute or
maintain a cause of action or any claim
based on a restrictive covenant against
any individual formerly employed by
Premier who was terminated in 2009.
Premier has consented to waive all such
claims and causes of action throughout
the United States of America.
Thanks for your consideration.
Schedule
jlentini on DSKJ8SOYB1PROD with NOTICES
should be considered null and void.
Election Systems & Software (ES&S)
should not have the right to ever pursue
former Premier Associates in legal
matters with respect to those
Agreements. The Agreements should
not be void as of the Date of the Final
Judgment as some of these former
employees have already started working
with other vendors. These former
employees would be subject to legal
action from ES&S since they wouldn’t
fall within the window set forth in the
Final Judgment. These Agreements
should be considered void as of the date
of the employee’s termination date. Also
the agreements are already set to expire
in September 2011 so there is no reason
to have a 6 month window for any
acquirer to hire these former employees.
These former employees should also be
able to go to work for any company in
the election industry, not just the
acquirer, without fear or threat from
ES&S. Below is my consideration to the
wording set forth in the Final Judgment.
All restrictive covenants contained
within any employment agreement or
separation agreement entered into
between Premier Election Solutions,
Inc., its parent corporation, subsidiaries,
officers, directors, supervisors and/or
representatives (collectively referred to
as ‘‘Premier’’) and any individuals
formerly employed by Premier who
were terminated in 2009 are declared
void. Premier may not institute or
maintain a cause of action or any claim
based on a restrictive covenant against
any individual formerly employed by
Premier who was terminated in 2009.
Premier has consented to waive all such
claims and causes of action throughout
the United States of America.
Thanks for your consideration.
The Public
Attention: Maribeth Petrizzi, Chief,
Litigation II Section, Antitrust
Division, United States Department of
Justice, 450 Fifth Street, NW.; Suite
8700, Washington, DC 20530.
United States of America, et al.,
Plaintiff, v. Election Systems &
Software, Inc., Defendant
As a friend of a former employee of
Premier Election Solutions who was
terminated as a result of this illegal
acquisition by Election Systems &
Software (ES&S), I would like to file a
suggestion to the court. The former
employees of Premier Elections should
not be restricted to continue working
their trade in elections or be prevented
from earning a living for their families
as a result of a noncompetition
agreement and Separation Agreement in
this illegal purchase. The agreements
VerDate Mar<15>2010
21:02 Jun 25, 2010
Jkt 220001
The Public.
[FR Doc. 2010–15368 Filed 6–25–10; 8:45 am]
BILLING CODE 4410–11–M
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Registration
By Notice dated March 16, 2010, and
published in the Federal Register on
March 24, 2010 (75 FR 14188), Sigma
Aldrich Manufacturing LLC., 3500
Dekalb Street, St. Louis, Missouri 63118,
made application by renewal to the
Drug Enforcement Administration
(DEA) to be registered as an importer of
the basic classes of controlled
substances listed in schedules I and II:
PO 00000
Frm 00065
Fmt 4703
Sfmt 4703
Drug
Cathinone (1235) ..........................
Methcathinone (1237) ...................
Aminorex (1585) ...........................
Gamma
Hydroxybutyric
Acid
(2010).
Methaqualone (2565) ....................
Alpha-ethyltryptamine (7249) ........
Ibogaine (7260) .............................
Lysergic acid diethylamide (7315)
Marihuana (7360) .........................
Tetrahydrocannabinols (7370) ......
Mescaline (7381) ..........................
4-Bromo-2,5dimethoxyamphetamine (7391).
4-Bromo-2,5dimethoxyphenethylamine
(7392).
4-Methyl-2,5dimethoxyamphetamine (7395).
2,5-Dimethoxyamphetamine
(7396).
3,4-Methylenedioxyamphetamine
(7400).
N-Hydroxy-3,4methylenedioxyamphetamine
(7402).
3,4-Methylenedioxy-Nethylamphetamine (7404).
3,4Methylenedioxymethamphetamine (MDMA) (7405).
4-Methoxyamphetamine (7411) ....
Bufotenine (7433) .........................
Diethyltryptamine (7434) ...............
Dimethyltryptamine (7435) ............
Psilocybin (7437) ..........................
Psilocyn (7438) .............................
1-[1-(2Thienyl)cyclohexyl]piperidine
(7470).
N-Benzylpiperazine (BZP) (7493)
Heroin (9200) ................................
Normorphine (9313) ......................
Etonitazene (9624) .......................
Amphetamine (1100) ....................
Methamphetamine (1105) .............
Methylphenidate (1724) ................
Amobarbital (2125) .......................
Pentobarbital (2270) .....................
Secobarbital (2315) ......................
Glutethimide (2550) ......................
Nabilone (7379) ............................
Phencyclidine (7471) ....................
Cocaine (9041) .............................
Codeine (9050) .............................
Diprenorphine (9058) ....................
Oxycodone (9143) ........................
Hydromorphone (9150) .................
Diphenoxylate (9170) ....................
Ecgonine (9180) ...........................
Ethylmorphine (9190) ...................
Hydrocodone (9193) .....................
Levorphanol (9220) .......................
Meperidine (9230) .........................
Methadone (9250) ........................
Morphine (9300) ...........................
Thebaine (9333) ...........................
Opium, powdered (9639) ..............
Levo-alphacetylmethadol (9648) ..
Oxymorphone (9652) ....................
Fentanyl (9801) .............................
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
The company plans to import the
listed controlled substances for sale to
E:\FR\FM\28JNN1.SGM
28JNN1
36694
Federal Register / Vol. 75, No. 123 / Monday, June 28, 2010 / Notices
research facilities for drug testing and
analysis.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a),
and determined that the registration of
Sigma Aldrich Manufacturing LLC. to
import the basic classes of controlled
substances is consistent with the public
interest, and with United States
obligations under international treaties,
conventions, or protocols in effect on
May 1, 1971, at this time. DEA has
investigated Sigma Aldrich
Manufacturing LLC. to ensure that the
company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with State and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 952(a)
and 958(a), and in accordance with 21
CFR 1301.34, the above named company
is granted registration as an importer of
the basic classes of controlled
substances listed.
Dated: June 17, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Registration
By Notice dated December 17, 2009,
and published in the Federal Register
on January 4, 2010 (75 FR 160), Mylan
Technologies Inc., 110 Lake Street, Saint
Albans, Vermont 05478, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as an importer of the basic
classes of controlled substances listed in
schedule II:
Schedule
jlentini on DSKJ8SOYB1PROD with NOTICES
II
II
The company plans to import the
listed controlled substances for
analytical research and clinical trials.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a),
and determined that the registration of
Mylan Technologies Inc. to import the
basic classes of controlled substances is
21:02 Jun 25, 2010
Jkt 220001
BILLING CODE 4410–09–P
Dated: June 17, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2010–15555 Filed 6–25–10; 8:45 am]
BILLING CODE 4410–09–P
Importer of Controlled Substances;
Notice of Registration
DEPARTMENT OF JUSTICE
VerDate Mar<15>2010
[FR Doc. 2010–15556 Filed 6–25–10; 8:45 am]
Meridian Medical Technologies to
import the basic classes of controlled
substances is consistent with the public
interest, and with United States
obligations under international treaties,
conventions, or protocols in effect on
May 1, 1971, at this time. DEA has
investigated Meridian Medical
Technologies to ensure that the
company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 952(a)
and § 958(a), and in accordance with 21
CFR 1301.34, the above named company
is granted registration as an importer of
the basic classes of controlled
substances listed.
Drug Enforcement Administration
BILLING CODE 4410–09–P
Methylphenidate (1724) ...............
Fentanyl (9801) ...........................
Dated: June 17, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
DEPARTMENT OF JUSTICE
[FR Doc. 2010–15557 Filed 6–25–10; 8:45 am]
Drug
consistent with the public interest, and
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971, at
this time. DEA has investigated Mylan
Technologies Inc. to ensure that the
company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 952(a)
and 958(a), and in accordance with 21
CFR 1301.34, the above named company
is granted registration as an importer of
the basic classes of controlled
substances listed.
By Notice dated March 16, 2010, and
published in the Federal Register on
March 24, 2010 (75 FR 14187), Meridian
Medical Technologies, 2555 Hermelin
Drive, St. Louis, Missouri 63144, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as an importer of
Morphine (9300), a basic class of
controlled substance listed in schedule
II.
The company manufactures a product
containing morphine in the United
States. The company exports this
product to customers around the world,
including in Europe. The company has
been asked to ensure that its product
sold to European customers meets
standards established by the European
Pharmacopeia, which is administered
by the Directorate for the Quality of
Medicines (EDQM). In order to ensure
that its product will meet European
specifications, the company seeks to
import morphine supplied by EDQM to
use as reference standards. This is the
sole purpose for which the company
will be authorized by DEA to import
morphine.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a),
and determined that the registration of
PO 00000
Frm 00066
Fmt 4703
Sfmt 4703
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Registration
By Notice dated March 16, 2010, and
published in the Federal Register on
March 24, 2010 (75 FR 14186), Roche
Diagnostics Operations Inc., Attn:
Regulatory Compliance, 9115 Hague
Road, Indianapolis, Indiana 46250,
made application by renewal to the
Drug Enforcement Administration
(DEA) to be registered as an importer of
the basic classes of controlled
substances listed in schedules I and II:
Drug
Lysergic acid diethylamide (7315)
Tetrahydrocannabinols (7370) ....
Alphamethadol (9605) .................
Cocaine (9041) ............................
Ecgonine (9180) ..........................
Methadone (9250) .......................
Morphine (9300) ..........................
Schedule
I
I
I
II
II
II
II
The company plans to import the
listed controlled substances for the
manufacture of diagnostic products for
distribution to its customers.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a),
and determined that the registration of
Roche Diagnostics Operations Inc. to
E:\FR\FM\28JNN1.SGM
28JNN1
]]>Agencies
[Federal Register Volume 75, Number 123 (Monday, June 28, 2010)]
[Notices]
[Pages 36693-36694]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-15557]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Registration
By Notice dated March 16, 2010, and published in the Federal
Register on March 24, 2010 (75 FR 14188), Sigma Aldrich Manufacturing
LLC., 3500 Dekalb Street, St. Louis, Missouri 63118, made application
by renewal to the Drug Enforcement Administration (DEA) to be
registered as an importer of the basic classes of controlled substances
listed in schedules I and II:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Cathinone (1235)............................ I
Methcathinone (1237)........................ I
Aminorex (1585)............................. I
Gamma Hydroxybutyric Acid (2010)............ I
Methaqualone (2565)......................... I
Alpha-ethyltryptamine (7249)................ I
Ibogaine (7260)............................. I
Lysergic acid diethylamide (7315)........... I
Marihuana (7360)............................ I
Tetrahydrocannabinols (7370)................ I
Mescaline (7381)............................ I
4-Bromo-2,5-dimethoxyamphetamine (7391)..... I
4-Bromo-2,5-dimethoxyphenethylamine (7392).. I
4-Methyl-2,5-dimethoxyamphetamine (7395).... I
2,5-Dimethoxyamphetamine (7396)............. I
3,4-Methylenedioxyamphetamine (7400)........ I
N-Hydroxy-3,4-methylenedioxyamphetamine I
(7402).
3,4-Methylenedioxy-N-ethylamphetamine (7404) I
3,4-Methylenedioxymethamphetamine (MDMA) I
(7405).
4-Methoxyamphetamine (7411)................. I
Bufotenine (7433)........................... I
Diethyltryptamine (7434).................... I
Dimethyltryptamine (7435)................... I
Psilocybin (7437)........................... I
Psilocyn (7438)............................. I
1-[1-(2-Thienyl)cyclohexyl]piperidine (7470) I
N-Benzylpiperazine (BZP) (7493)............. I
Heroin (9200)............................... I
Normorphine (9313).......................... I
Etonitazene (9624).......................... I
Amphetamine (1100).......................... II
Methamphetamine (1105)...................... II
Methylphenidate (1724)...................... II
Amobarbital (2125).......................... II
Pentobarbital (2270)........................ II
Secobarbital (2315)......................... II
Glutethimide (2550)......................... II
Nabilone (7379)............................. II
Phencyclidine (7471)........................ II
Cocaine (9041).............................. II
Codeine (9050).............................. II
Diprenorphine (9058)........................ II
Oxycodone (9143)............................ II
Hydromorphone (9150)........................ II
Diphenoxylate (9170)........................ II
Ecgonine (9180)............................. II
Ethylmorphine (9190)........................ II
Hydrocodone (9193).......................... II
Levorphanol (9220).......................... II
Meperidine (9230)........................... II
Methadone (9250)............................ II
Morphine (9300)............................. II
Thebaine (9333)............................. II
Opium, powdered (9639)...................... II
Levo-alphacetylmethadol (9648).............. II
Oxymorphone (9652).......................... II
Fentanyl (9801)............................. II
------------------------------------------------------------------------
The company plans to import the listed controlled substances for
sale to
[[Page 36694]]
research facilities for drug testing and analysis.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and 952(a), and determined that the
registration of Sigma Aldrich Manufacturing LLC. to import the basic
classes of controlled substances is consistent with the public
interest, and with United States obligations under international
treaties, conventions, or protocols in effect on May 1, 1971, at this
time. DEA has investigated Sigma Aldrich Manufacturing LLC. to ensure
that the company's registration is consistent with the public interest.
The investigation has included inspection and testing of the company's
physical security systems, verification of the company's compliance
with State and local laws, and a review of the company's background and
history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in
accordance with 21 CFR 1301.34, the above named company is granted
registration as an importer of the basic classes of controlled
substances listed.
Dated: June 17, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2010-15557 Filed 6-25-10; 8:45 am]
BILLING CODE 4410-09-P
